Skip to main content
Crescita Therapeutics Inc. (TSX:CTX)
Canada flag Canada · Delayed Price · Currency is CAD
0.750
0.00 (0.00%)
Apr 28, 2026, 1:49 PM EST

Crescita Therapeutics Revenue

In the year 2025, Crescita Therapeutics had annual revenue of 21.12M CAD with 7.85% growth. Crescita Therapeutics had revenue of 5.96M in the quarter ending December 31, 2025, a decrease of -13.72%.

Revenue
21.12M
Revenue Growth
+7.85%
P/S Ratio
0.66
Revenue / Employee
n/a
Employees
62
Market Cap
13.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202521.12M1.54M7.85%
Dec 31, 202419.58M2.06M11.75%
Dec 31, 202317.52M-6.00M-25.52%
Dec 31, 202223.53M6.76M40.29%
Dec 31, 202116.77M1.13M7.22%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
1CM Inc. 75.01M
Red White & Bloom Brands 70.97M
Red Light Holland 4.17M
Voyageur Pharmaceuticals 30.96K
Avicanna 25.48M
Ayr Wellness 650.97M
Medicure 28.86M
Nextleaf Solutions 11.40M
Revenue Rankings

Crescita Therapeutics News

More News